Lazard Asset Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-215,728
Closed -$19.2M 1078
2017
Q1
$19.2M Sell
215,728
-239,641
-53% -$19.7M 0.04% 306
2016
Q4
$32.2M Sell
455,369
-406,307
-47% -$30.3M 0.07% 208
2016
Q3
$68.1M Sell
861,676
-48,631
-5% -$4.15M 0.14% 122
2016
Q2
$82.6M Sell
910,307
-421,700
-32% -$35.7M 0.17% 106
2016
Q1
$113M Sell
1,332,007
-35,504
-3% -$2.64M 0.25% 91
2015
Q4
$108M Sell
1,367,511
-137,123
-9% -$10.8M 0.25% 91
2015
Q3
$106M Sell
1,504,634
-101,694
-6% -$8.37M 0.25% 104
2015
Q2
$145M Sell
1,606,328
-178,462
-10% -$17.2M 0.3% 93
2015
Q1
$179M Sell
1,784,790
-126,503
-7% -$12.8M 0.39% 79
2014
Q4
$192M Sell
1,911,293
-176,349
-8% -$17.6M 0.41% 63
2014
Q3
$201M Sell
2,087,642
-235,208
-10% -$22.3M 0.43% 64
2014
Q2
$216M Sell
2,322,850
-136,290
-6% -$11.9M 0.45% 67
2014
Q1
$204M Sell
2,459,140
-180,628
-7% -$14.6M 0.46% 70
2013
Q4
$221M Sell
2,639,768
-112,366
-4% -$9.15M 0.49% 62
2013
Q3
$204M Buy
2,752,134
+469,495
+21% +$35.2M 0.48% 62
2013
Q2
$181M Buy
+2,282,639
New +$183M 0.43% 67

Other funds holding MJN

Lazard Asset Management's MJN Position: Q2 2017 in Review

Lazard Asset Management sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 215,728 shares — an estimated $19.2M sold.

Lazard Asset Management first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $221M in Q4 2013. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Lazard Asset Management reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Lazard Asset Management sold 215,728 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $19.2M.
  • Lazard Asset Management first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Lazard Asset Management's Mead Johnson Nutrition Company position peaked at $221M in Q4 2013.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Lazard Asset Management's 13F filing for Q2 2017, filed 11 Aug 2017.